Here, we provide evidence that measurements of serum IFN-α and IL-33 concentration are useful for the diagnosis and evaluation of disease activity in patients with type 1 AIP/IgG4-RD. The gene discussed is IFNA1; the disease is autoimmune pancreatitis type 1.